Bond Bristol Myers-Squibb 0% ( USU11009BF03 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price | 100 % ⇌ |
| Country | United States
|
| ISIN code |
USU11009BF03 ( in USD )
|
| Interest rate | 0% |
| Maturity | 16/05/2022 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 500 000 000 USD |
| Cusip | U11009BF0 |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$500,000,000 0% bond (CUSIP: U11009BF0, ISIN: USU11009BF03), issued in the United States, matured on May 16, 2022, and has been redeemed at 100% of face value. |
Français
Italiano
United States